Endometriosis is a complex gynecological disease that affects more than 10% of women in their reproductive years. While surgery can provide temporary relief from women’s pain, symptoms often return in as many as 75% of cases within two years. Previous literature has contributed to theories about the development of endometriosis; however, the exact pathogenesis and etiology remain elusive. We conducted a preliminary investigation into the influence of primary endometrial cells (ECs) on the development and progression of endometriosis. In vitro studies, they were involved in inducing Lipopolysaccharide (LPS) in rat-isolated primary endometrial cells, which resulted in increased nuclear factor-kappa B (NF-κB) and vascular endothelial growth factor (VEGF) mRNA gene expression (quantitative polymerase chain reaction analysis, qPCR) and protein expression (western blot analysis). Additionally, in vivo studies utilized autogenic and allogeneic transplantations (rat to rat) to investigate endometriosis-like lesion cyst size, body weight, protein levels (immunohistochemistry), and mRNA gene expression. These studies demonstrated that estrogen upregulates the gene and protein regulation of cytoskeletal (CK)-18, transforming growth factor-β (TGF-β), VEGF, and tumor necrosis factor (TNF)-α, particularly in the peritoneum. These findings may influence cell proliferation, angiogenesis, fibrosis, and inflammation markers. Consequently, this could exacerbate the occurrence and progression of endometriosis.
Background/Objectives: MicroRNAs released into spent culture medium (SCM) may reflect embryo developmental status, but their relationship with blastocyst morphology and time-lapse morphokinetic behavior remains incompletely understood. This prospective study aimed to investigate whether selected SCM microRNAs are associated with blastocyst morphological grade and early morphokinetic dynamics in human embryos. Methods: A total of 432 SCM samples were collected from embryos cultured in a time-lapse incubation system between October 2018 and July 2020. Blastocysts were classified as good, fair, or poor quality according to morphological grading. The expression levels of six candidate microRNAs, including miR-182-5p, miR-302a-3p, miR-372-3p, miR-373-3p, miR-518a-3p, and miR-519d-3p, were quantified using real-time quantitative polymerase chain reaction. Associations between microRNA expression, embryo morphology, and morphokinetic parameters were analyzed using GEE, multivariate logistic regression, and receiver operating characteristic (ROC) analysis. Results: After accounting for within-patient clustering using GEE, good-quality embryos showed significantly lower expression of miR-372-3p and miR-373-3p than poor-quality embryos. On multivariate logistic regression, lower miR-372-3p expression remained independently associated with optimal t5–t2 interval after adjustment, whereas its associations with optimal CC3 and the combined outcomes were attenuated. ROC analysis demonstrated modest discriminatory ability for miR-372-3p alone (AUC = 0.644), whereas embryo morphology alone achieved an AUC of 0.731, and the combined model incorporating morphology and miR-372-3p reached the highest AUC of 0.752. Conclusions: These findings suggest that SCM microRNA expression is associated with embryo development. In particular, reduced miR-372-3p expression may reflect more favorable blastocyst morphology and early developmental dynamics, supporting its potential as an adjunctive molecular indicator of embryo quality. Further validation incorporating embryo ploidy status and clinical outcomes is warranted before clinical application.